The increased drug load enabled by the nanoformed particles also allows smaller implants with sustained release properties to be developed.
Laurus will also provide funding for the clinical trials and will launch these products in India and emerging markets
Convergent action on AMR identified as an important area of intervention
Panacea Biotec has announced the launch of its new range of high-quality pediatric food & nutritional products
Investment enables development of revolutionary multi-omic platform using super-resolution imaging technology for earlier disease detection and accelerated discovery of therapeutics
Economic analysis of cost of Vall d’Hebron University Hospital Stroke Unit shows direct-to-angio stroke pathway can save more than USD 3,000 per patient
_256_384.jpeg)
Launched Pathology Laboratory in Vijayawada offering a wide range of best-in-class diagnostic services with over 2500+ tests
Samsung Biologics will provide Pfizer with additional capacity for large-scale manufacturing for a multi-product biosimilars portfolio
Patent Term Extension is designed to restore some of the patent life lost during the regulatory review process for new drugs.
The randomised, multi-centre, evaluator blinded, parallel group, active controlled Phase 3 trial is being led by Lanhzou Biotechnique Development
Subscribe To Our Newsletter & Stay Updated
